FDA Inspection 757123 — Statline (Division Of MTF Biologics)
The FDA completed an inspection of Statline (Division Of MTF Biologics) on Dec 14, 2011 in Edison, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Dec 14, 2011
- Fiscal Year
- 2012
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Edison, NJ (United States)